Reginald Edward Greene, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aspergillosis | 5 | 2007 | 235 | 0.860 |
Why?
|
| Lung Diseases, Fungal | 3 | 2007 | 122 | 0.810 |
Why?
|
| Amphotericin B | 2 | 2007 | 137 | 0.360 |
Why?
|
| Radiography, Thoracic | 8 | 2014 | 1265 | 0.330 |
Why?
|
| Triazoles | 3 | 2007 | 907 | 0.290 |
Why?
|
| Lung | 9 | 2021 | 9826 | 0.260 |
Why?
|
| Models, Economic | 1 | 2007 | 713 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2021 | 20086 | 0.180 |
Why?
|
| Lung Diseases | 4 | 2014 | 1884 | 0.170 |
Why?
|
| Subtraction Technique | 1 | 2002 | 525 | 0.170 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2012 | 654 | 0.160 |
Why?
|
| Radiographic Image Enhancement | 3 | 2014 | 885 | 0.160 |
Why?
|
| Pyrimidines | 2 | 2007 | 2933 | 0.160 |
Why?
|
| Antifungal Agents | 3 | 2006 | 729 | 0.140 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 66 | 0.100 |
Why?
|
| Silicones | 1 | 2012 | 248 | 0.100 |
Why?
|
| Lymphatic Diseases | 1 | 2012 | 324 | 0.090 |
Why?
|
| Chronobiology Disorders | 1 | 2010 | 74 | 0.090 |
Why?
|
| Allied Health Personnel | 1 | 2010 | 162 | 0.080 |
Why?
|
| Berylliosis | 1 | 1988 | 8 | 0.080 |
Why?
|
| Stomach Diseases | 1 | 1989 | 134 | 0.080 |
Why?
|
| Pulmonary Circulation | 1 | 2009 | 739 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 959 | 0.070 |
Why?
|
| Work Schedule Tolerance | 1 | 2010 | 565 | 0.070 |
Why?
|
| Decision Trees | 1 | 2007 | 506 | 0.070 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2005 | 13 | 0.070 |
Why?
|
| Aspergillus fumigatus | 1 | 2005 | 150 | 0.060 |
Why?
|
| Myeloproliferative Disorders | 1 | 2009 | 603 | 0.060 |
Why?
|
| Asbestosis | 1 | 2002 | 82 | 0.050 |
Why?
|
| Pleural Cavity | 1 | 2021 | 22 | 0.050 |
Why?
|
| HIV Infections | 3 | 2012 | 16678 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2006 | 847 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2009 | 807 | 0.050 |
Why?
|
| Pleural Diseases | 1 | 2002 | 139 | 0.050 |
Why?
|
| Pneumonia | 1 | 2012 | 2117 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2006 | 1269 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 2658 | 0.040 |
Why?
|
| Respiratory Mechanics | 2 | 2009 | 681 | 0.040 |
Why?
|
| Radiology | 1 | 2010 | 2090 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2012 | 2557 | 0.030 |
Why?
|
| Survival Rate | 2 | 2007 | 12773 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 3038 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2012 | 9144 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5385 | 0.030 |
Why?
|
| Respiratory Function Tests | 2 | 2009 | 1613 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2006 | 10248 | 0.030 |
Why?
|
| Humans | 20 | 2021 | 742088 | 0.030 |
Why?
|
| Endotoxins | 1 | 1994 | 525 | 0.030 |
Why?
|
| Adult | 9 | 2014 | 213712 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 15056 | 0.020 |
Why?
|
| Middle Aged | 9 | 2014 | 213127 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 664 | 0.020 |
Why?
|
| Nitrogen Radioisotopes | 1 | 2009 | 44 | 0.020 |
Why?
|
| Bronchiectasis | 1 | 2010 | 128 | 0.020 |
Why?
|
| Stomach Ulcer | 1 | 1989 | 125 | 0.020 |
Why?
|
| Supine Position | 1 | 2009 | 204 | 0.020 |
Why?
|
| Tungsten Compounds | 1 | 1988 | 10 | 0.020 |
Why?
|
| Tungsten | 1 | 1988 | 16 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 1994 | 672 | 0.020 |
Why?
|
| Male | 11 | 2014 | 349538 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1994 | 1538 | 0.020 |
Why?
|
| Metallurgy | 1 | 1988 | 94 | 0.020 |
Why?
|
| Cobalt | 1 | 1988 | 158 | 0.020 |
Why?
|
| Transsexualism | 1 | 2012 | 177 | 0.020 |
Why?
|
| Cough | 1 | 2012 | 555 | 0.020 |
Why?
|
| Aged | 7 | 2014 | 162944 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2009 | 381 | 0.020 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2010 | 222 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 675 | 0.020 |
Why?
|
| Aspergillus | 1 | 2006 | 85 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 12958 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15108 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 1994 | 1155 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2010 | 77098 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2009 | 1866 | 0.020 |
Why?
|
| Adolescent | 3 | 2009 | 85649 | 0.020 |
Why?
|
| Dogs | 1 | 1989 | 3910 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 19862 | 0.010 |
Why?
|
| Dyspnea | 1 | 2012 | 1298 | 0.010 |
Why?
|
| Female | 8 | 2014 | 379592 | 0.010 |
Why?
|
| ROC Curve | 1 | 1989 | 3528 | 0.010 |
Why?
|
| Radiography | 2 | 1994 | 7010 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1988 | 1472 | 0.010 |
Why?
|
| Sepsis | 1 | 1994 | 2589 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1989 | 1327 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2009 | 4024 | 0.010 |
Why?
|
| Child | 1 | 2006 | 77478 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14720 | 0.010 |
Why?
|
| Biopsy | 1 | 2010 | 6756 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 2002 | 498 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 2271 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1994 | 9274 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1989 | 3679 | 0.010 |
Why?
|
| Oxygen | 1 | 1988 | 4169 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11363 | 0.010 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 1994 | 25 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13256 | 0.010 |
Why?
|
| HIV-1 | 1 | 2012 | 6934 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 6259 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 8925 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2010 | 62966 | 0.010 |
Why?
|
| Spirometry | 1 | 1994 | 862 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 13403 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 40955 | 0.010 |
Why?
|
| Time Factors | 2 | 1994 | 40054 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 1988 | 24913 | 0.010 |
Why?
|
| X-Ray Intensifying Screens | 1 | 1989 | 32 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1994 | 1839 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 1994 | 860 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1988 | 87 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1988 | 922 | 0.000 |
Why?
|
| Carbon Monoxide | 1 | 1988 | 531 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 57683 | 0.000 |
Why?
|
| Respiratory Sounds | 1 | 1988 | 693 | 0.000 |
Why?
|
| Linear Models | 1 | 1994 | 5948 | 0.000 |
Why?
|
| Forced Expiratory Volume | 1 | 1988 | 1741 | 0.000 |
Why?
|
| Absorptiometry, Photon | 1 | 1989 | 1726 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 56350 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1994 | 12017 | 0.000 |
Why?
|
| United States | 1 | 1988 | 69693 | 0.000 |
Why?
|
| Animals | 1 | 1989 | 168561 | 0.000 |
Why?
|
| Incidence | 1 | 1994 | 20928 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 39004 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1994 | 53187 | 0.000 |
Why?
|
| Risk Factors | 1 | 1994 | 72145 | 0.000 |
Why?
|